Social Media Discovery – Fighting Fake News and Disinformation – Fighting Covid-19
Signed agreement with major worldwide media & entertainment company for COVID-19 testing and related services - expected to be worth over CAD $20MM for the initial nine months
Mr. Gunter’s engineering background is rooted in big data analysis and machine learning at scale. Working with Sequoia Capital and Lightspeed Venture Partners, Marshall was responsible for bringing Varagesale to the mass market. Marshall took Varagesale from a one room shop to a powerhouse engineering department of 60 plus people and played a leading role in their $35-million-dollar raise. Marshall led the team that built iSentium’s sentiment engine. iSentium uses patented Natural Language Processing (NLP) to extract sentiment from unstructured social content then instantly transforms it into highly actionable indicators in finance, brand management and politics, handling billions of data points to harness the power of the masses as they tweet and text.
Don Shim, CPA, CA
Mr. Shim has led a successful accounting and finance career in both the US and Canada. He brings a wealth of knowledge to the team with his expertise in auditing publicly- traded junior mining companies and high-tech industries. Member of the Chartered Professional Accountants of British Columbia and a Certified Public Accountant registered in the State of Illinois, United States.
Audit partner on numerous audit engagements for various publicly traded companies, primarily focusing on junior mining, oil and gas, pharmaceutical, and high-tech industries.
Mr. Shim also assisted various start-up companies in achieving public listings on the TSX Venture Exchange, Canadian Securities Exchange and the OTC Market.
In addition, Mr. Shim teaches accounting at a local college in Vancouver and acts as a facilitator at CPA Western School of Business, mentoring CPA candidates enrolled in the CPA Professional Education Program.
Hon. James S. Peterson, P.C.
Independant Board Member
Jim Peterson with his government experience on the world stage brings a wealth of knowledge in strategic planning and government affairs. He will be using this experience in helping Datametrex engage with world governments to bring more testing to the general population to eradicate the spread of the COVID-19 virus.
Jim obtained his BA and LLB from Western University, his LLM from Columbia University and his DCL from McGill University. He also taught Law at University of Toronto, and worked for the UN International development organization in Vienna, Khartoum, and Kuala Lumpur on International joint business ventures in developing countries. He is a Member of the Ontario Bar Association, the Canadian Bar Association, and is a Co-Chair of the Canada-US Law Institute. Jim has also served for the Government of Canada as Minister of International Trade, Secretary of State (International Financial Institutions), and Chair of the House of Commons Standing Committee on Finance. While a Cabinet Minister, Jim represented Canada at the World Trade Organization's Doha round of negotiations, which were focused on expanding trade and investment in leading emerging markets Brazil, Russia, India and China, and with complex issues related to trade with Canada's NAFTA partners, the European Union, the Middle East and the Americas.
Andrew Ryu is a seasoned and experienced entrepreneur and operator in public and private companies. Graduate of McMaster University (1999) and University of Toronto (2000). Founder and CEO of TLA Inc. (1997-2005), President of business development of Archer Education Group (2005-2008), and founder and CEO of Loyalist Group Limited (TSXV: LOY) (2009-2014), which was nominated as the top TSXV company in 2013, ranked fourth in 2014, and was the top pick of the street in 2014. He served as CEO of Cozumo Inc. (2015-2016). He is currently serving as CEO and Chairman of Datametrex AI Limited (TSXV: DM) and Chairman of Graph Blockchain Inc. (CSE: GBLC). He was nominee of EY entrepreneur of the year in 2014.
Dr. Alexander MacGregor
A leader in the fields of pharmaceutical technology, research, and training, Dr. MacGregor has served as the President and Dean of Faculty of the Toronto Institute of Pharmaceutical Technology (TIPT®) since 1992.
The holder of several scientific patents, Dr. MacGregor currently oversees clinical testing trials of several drugs in the areas of cholesterol lowering, diabetes, anti-infective, post-operative pain, epilepsy, and congestive heart failure.
Dr. MacGregor obtained his Ph.D. in clinical pharmacology from the University of London Postgraduate Medical School after earning B.Sc. (Honors) in Medical Biochemistry from the Cardif University in Wales. In 1997, Dr. MacGregor completed a Master-Class Certification Program in Pharmaceutical Technology from the European Continuing Education College at the University of Liverpool.